Deane F Mosher

Title: Deane F Mosher: Innovator in Medical Research

Introduction

Deane F Mosher is a prominent inventor based in Madison, WI (US). He has made significant contributions to the field of medical research, particularly in the area of inflammation and gene encoding. With a total of 9 patents to his name, Mosher's work has had a substantial impact on the development of new therapeutic methods.

Latest Patents

One of Mosher's latest patents is titled "Method to inhibit neutrophil recruitment to damaged tissue using myeloid-derived growth factor." This innovative method aims to inhibit neutrophil recruitment to damaged tissue, thereby reducing inflammation in a subject. The process involves administering an anti-inflammatory amount of a myeloid-derived growth factor (MYDGF). Additionally, the patent discloses corresponding pharmaceutical compositions containing MYDGF. Another notable patent is "Transglutaminase and gene encoding same," which describes a pair of degenerate oligonucleotide primers that can amplify transglutaminase-specific fragments of known transglutaminase genes. These primers are also utilized to obtain new transglutaminase gene products, with the nucleotide sequence of a novel transglutaminase gene (termed TG.sub.X) presented in the patent.

Career Highlights

Deane F Mosher is associated with the Wisconsin Alumni Research Foundation, where he continues to advance his research and innovation in the medical field. His work has been instrumental in developing new methods and compositions that address critical health issues.

Collaborations

Mosher has collaborated with notable colleagues, including Jane M Sottile and Daniel P Aeschlimann, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Deane F Mosher's contributions to medical research through his patents and collaborations highlight his role as a leading inventor in the field. His innovative methods and compositions continue to pave the way for advancements in healthcare.